Human immunodeficiency virus type 1 phenotypes in children with advanced disease treated with long-term zalcitabine

R M Viani1, I L Smith, S A Spector

  • 1Department of Pediatrics, University of California at San Diego, La Jolla 92093-0672, USA.

Insights

Zalcitabine monotherapy in HIV-1 infected children showed a low incidence of drug resistance. Some patients experienced a switch from syncytium-inducing (SI) to non-SI (NSI) HIV-1 phenotypes during treatment.

Area of Science:

  • Virology
  • Pediatric Infectious Diseases
  • Antiretroviral Therapy

Background:

  • Human immunodeficiency virus type 1 (HIV-1) infection in children requires effective antiretroviral strategies.
  • Zidovudine-experienced children were enrolled in a trial evaluating zalcitabine monotherapy.
  • Understanding viral phenotype and resistance is crucial for treatment selection.

Purpose of the Study:

  • To assess the syncytium-inducing (SI) phenotype and zalcitabine resistance in HIV-1 isolates from children.
  • To evaluate changes in viral phenotype during zalcitabine monotherapy.
  • To inform combination antiretroviral drug selection.

Main Methods:

  • Prospective trial of zalcitabine (dideoxycytidine) monotherapy in 38 HIV-1 infected children.
  • Analysis of baseline and posttreatment HIV-1 isolates for SI/NSI phenotype.
  • In vitro drug susceptibility assays to determine zalcitabine resistance.

Main Results:

  • Twenty baseline isolates were SI, and 18 were NSI.
  • Phenotype stability was observed in most patients (>44 weeks of treatment).
  • Low incidence of zalcitabine resistance (3%) and some SI-to-NSI phenotype reversion (20%) were noted.

Conclusions:

  • Zalcitabine monotherapy demonstrates a low rate of resistance development in this pediatric cohort.
  • A significant proportion of patients showed a switch from SI to NSI HIV-1 phenotype.
  • These findings are valuable for guiding future antiretroviral treatment choices in children.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...